Power of Incentives among Pregnant Mothers: The outcomes of an Incentivized Smoking Cession Program
Methods: Baby and Me Tobacco Free uses a unique approach, combining cessation support specific to pregnant women, offering practical incentives, targeting low-income women, and monitoring success. In order to assess the benefits of the Baby and Me Tobacco Free program, researchers compared the outcomes to a basic standard of care model.
Results: In 2014, 428 pregnant mothers participated in the Baby and Me Tobacco Free program in Indiana. The smoking rates and birth outcomes were compared to the 3,280 participants in the state-funded prenatal care coordination program. Among participants in the Baby and Me Tobacco Free program, there was a 68% quit rate. Among participants in the standard prenatal care program there was a quit rate of 21%.
Conclusions: Implementing incentive-based smoking cessation programs could help in reducing smoking during pregnancy, which would directly impact the infant mortality rate. If 25% of pregnant smokers on Medicaid quit, estimated savings for U.S. are $10 to $13 million for birth annually.
Learning Areas:Administer health education strategies, interventions and programs
Assessment of individual and community needs for health education
Implementation of health education strategies, interventions and programs
Public health or related education
Public health or related research
Social and behavioral sciences
Describe the baby and Me Tobacco free program Compare outcomes from the Baby and Me Tobacco Free program and the state-funded prenatal care programs. Explain the role of incentives in smoking cessation.
Keyword(s): Infant Mortality, Maternal and Child Health
Qualified on the content I am responsible for because: I have been the Title V Coordinator for the past 3 years. I lead this project evaluation.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.